docBioPharma Asia 2015 38P.indd
download 
Report Transcription
BioPharma Asia 2015 38P.indd
New updated agenda 23 - 25 March 2015 Suntec Singapore Convention & Exhibition Centre, Singapore Navigating the future of Asia’s biopharmaceutical industry www.terrapinn.com/biopharmaasia “PROPER STRATEGIES TO TAKE ADVANTAGE OF THE HISTORICAL TSUNAMI, THE RISE OF ASIA” When you imagine Asia, what comes to mind? Porcelain, china? Congested, dusty roads? Cheap manufacturing costs or counterfeit markets? Asia has long been considered an emerging market, living in the shadow of Europe and the west. Learning from scientific breakthroughs in the US and replicating pharma manufacturing practices from Europe has given Asia a ‘copycat’ reputation. Christopher Gallen President, SK Biopharmaceuticals, South Korea Advancing Asia’s biopharmaceuticals industry Wednesday 25 March 2015, 09:45-10:30am Bringing a Korean spin-off to its current 12 IND approvals (US FDA) and strong pipelines of innovative drugs, Christopher has already taken advantage of the opportunities within Asia-Pacific’s biopharmaceutical market. He believes that success comes from seeing the future and getting there first, and currently Asian pharma companies p p are in a unique q p position to exercise his p philosophy. p y Asia is producing young, exciting R&D specialists, large manufacturing plants and copius amounts of patient data. It is time for Asia to breakaway from it’s outdated reputation. Green Cross Corp, based in Korea has vaccinated over 130 million people with Hepavax, a Hepatitis B vaccine. It also developed the first epidemic hemorragic fever vaccine, a chicken pox vaccine and the first AIDS diagnostic reagent. Serum Institute of India led by Dr Jadhav and his team has finally found the winning formula to manufacture large volumes of vaccines and is now a supplier to 140 countries. Simcere Pharmaceuticals from China has partnered with global brands like Merck & Co, and Bristol Myers Squibb to concentrate on therapies for cardiovascular diseases. And this is just one of China’s many companies that large MNCs are getting in bed with. It can no longer be said that Asia is lagging behind in the global pharmaceutical market. With the help of leading experts, BioPharma Asia will outline the future for Asia’s biopharma industry. Be a part of the biopharma revolution in Asia, book online now at www.terrapinn.com/biopharmaasia The Big Picture ROUNDTABLE DISCUSSIONS KEYNOTE PRESENTATIONS SECRET COCKTAIL PARTY EXHIBITION FREEMIUM AGENDA AWARDS DINNER ASIAN BIOTECH SHOWCASE 1-2-1 MEETINGS This is probably the most important event in the year on biopharma in terms of participants. It cannot be missed. JOHNSON & JOHNSON KEY SPEAKERS Angeline Lau Chih-Liang Chin Swapnil Ballal James Garner James Huang Kiyean Nam Koike Satoshi Regional Manager, Clinical & Medical Quality Operations Director and Site Lead, Imaging Senior Director, Quality Assurance Managing Partner Chief Executive Officer Biocon, India Kleiner Perkins Caufield Byers (KPCB), China Qurient Therapeutics, South Korea Director, Regulatory Affairs, Japan Merck Sharp Dohme (MSD), Singapore Head, Unit Development Operations, Asia R&D Sanofi Pasteur, Singapore Sanofi, Singapore Javed Rashid Jessie Gu Jianmei Kochling Jim Miller Jimmy Zhang May Wei Chief Scientific Officer and Head of Medical (Pharmaceuticals) Head, Translational Medicine, China Director, Quality Science and Analytical Technology Vice President & Head, Biologics Drug Substance Manufacturing Network Vice President, Transaction, Asia Pacific Global Regulatory Strategist Novartis, Singapore Novartis Institute for Biomedical Research, China Genzyme, USA Genentech, USA Johnson & Johnson Innovation Center, China Bayer Healthcare, China Amgen Astellas BioPharma KK, Japan Leena Menghaney Head, Access Campaign, South Asia Marcus Klein Matsumoto Jun Senior Director and Regional Medical Officer, Japan & AsiaPacific Principal Reviewer, Office of Cellular and Tissue-based Products Genzyme, Singapore Pharmaceutical and Medical Devices Agency (PMDA), Japan Pradip Patel Vinoop Goel Vice President & Head, Vaccine (Operations & Project) Regional Head, Airport, Passenger, Cargo &Security Zydus Cadila, India Janssen, Malaysia Mead Johnson Nutrition, Thailand International Air Transport Association, Singapore Sanjit Singh Lamba Shakilla Shahjihan Shirley Xu Head, Site Supply Yu-Kyeong Hwang Managing Director, Eisai Pharmaceuticals Regional Director, Government Affairs, Asia-Pacific Novartis Vaccines, China Director, Cell Therapy Research Center Doctors Without Borders/Medecis Sans Frontieres, India Nathan Kothandaraman Nyoman Mahardika Director, Market Access & Government Affairs Director, South Asia Supply Chain Allen Baharaff James Williams Jeroze Dalal Jin Shun Kam Man Hui Sagnik Sengupta Chief Executive Officer Non-Executive Director and Former Chief Executive Officer General Manager, Clinical Operations, India & Pakistan Deputy Group Director, Research General Manager, Distribution Dimerix Bioscience, Australia GlaxoSmithKline, India Director, Regulatory Policy & Intelligence, Japan – Asia-Pacific, Abbvie Singhealth, Singapore Bharat Serums and Vaccines, India Kathy Yu Nilesh Wadhwa Pankaj Monga Pik Pin Goh Rajesh Pednekar Silver Chen Swapnil Ballal Tom Geimer Victoria Elegant Yee Leong Teoh Senior Director, Business Development & Strategy Regional Director, Business Development & Strategy Director, Brand Protection (Asia), Director Head, Distribution Vice President, Medical, Clinical, Regulatory Affairs Chief Executive Officer Merck Serono, China Takeda Pharmaceticals, Singapore Pfizer Pharmaceuticals, India Senior Director, Quality Assurance Managing Director Clinical Research Center, Ministry of Health, Malaysia Senior Director, Regional Access Lead, Asia-Pacific/China Galmed Pharmaceuticals, Israel Johnson & Johnson, India Singapore Singapore Green Cross LabCell, South Korea Abbott, Singapore Pfizer, Hong Kong Biocon, India Madeline Pharmaceuticals, Australia Baxter International, China Singapore Clinical Research Institute (SCRI), Singapore Premium conference Day One LICENSING Tuesday 24 March 2015 Non-column purification to improve process economy 14.30 Cross-border technology transfer Listed in CNBC’s 2014 top 50 disruptors worldwide with its mRNA Therapeutics, “reprogramming cells to fight disease” 14.50 • Accelerating drug discovery via Moderna’s messenger RNA therapeutics™ • Addressing unmet global medical needs by “undruggable targets” • Commercializing pioneering platform technologies globally Stephan Bancel, President & Founding Chief Executive Officer, Moderna Therapeutics, USA 15.10 • Creating an innovative workplace with a top-down approach • Increasing risk appetite for greater innovation and eminent results in drug development • Case study: Change and growth at Toyota Motors & applications to the pharma industry David Gallon, Director, Strategic Insight & Innovation, Toyota Financial Services, USA Learning from the automotive industry—Defining the big word, “innovation” Preparing your product for Malaysia in the absence of reimbursement policies Stable cell lines for higher expression level of biotherapeutics Xiang Yang Zhu, Chief Executive Officer, Huaota Biopharm, China Novel cell line development strategies for monoclonal antibody production Nathan Kothandaraman, Director, Market Access & Government Affairs, Janssen, Malaysia Chi Wei-Kuang, Distinguished Scientist, Bioengineering Group, Development Centre for Biotechnology, Taiwan Cost-containment measures in Asia Streamlining drug discovery by efficient cell line development Silver Chen, Senior Director, Regional Access Lead, Asia-Pacific, Pfizer, Hong Kong Manjunath Ramarao, Group Director, Head, Disease Sciences and Technology, Bristol Myers-Squibb, India Government initiatives to develop Malaysia as a clinical hub Pik Pin Goh, Director, Clinical Research Centre, Ministry of Health, Malaysia Role of academic research organisations in clinical trials SUPPLY CHAIN MANAGEMENT 12:00 Jim Miller, Vice President & Head, Biologics Drug Substance Manufacturing Network, Genentech, USA Reserved for IMS Health Cargo security & pharma regulations: An IATA perspective Yee Leong Teoh, Chief Executive Officer, Singapore Clinical Research Institute (SCRI), Singapore Rodrigo Reyes, Regional Manager, Airport, Passenger, Cargo &Security, International Air Transport Association, Singapore Bringing early stage clinical research to Asia Realising flexible supply chain through postponement strategy James Garner, Head, Unit Development Operations, Asia R&D, Sanofi, Singapore Rajesh Pednekar, Head, Distribution Pfizer, India Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com to explore speaking opportunities in these sessions Table A: Strategic high quality cell culture production and manufacturing Leslie Chaney, Senior Director, Commercial Operations APAC, Global Director, Preclinical and Direct to Patient Services, Marken, USA Table A: Customising your embedded clinical development strategy Table A: Reverse logistics Table B: Pricing and reimbursement strategies in China and India Table B: Raw material testing & handling Table B: Clinical outsourcing models in Japan, Korea & Australia Table B: Managing 3PLs in a complicated supply chain network Table C: Pricing and reimbursement strategies in Singapore & Malaysia Table C: Cellular immunotherapy manufacturing facilities Table C: Clinical outsourcing models in India & Singapore Table C: Improving clinical supply importation and exportation Networking luncheon I Exhibition visit I 1-to-1 Partnering Nilesh Wadhwa, Regional Director, Business Development and Strategy, Takeda Pharmaceuticals, Singapore Steven S. Lee, Global Head, Technical Operations & Chief Executive Officer, Singapore Operations, Dr. Reddy’s Laboratories, Singapore Ajay Gautam, Executive Director & Head, External Collaborations, Asia & Emerging Markets iMed, AstraZeneca, China COLD CHAIN Is India still a desired destination for clinical trials? Jeroze Dalal, Head, Clinical Operations, India & Pakistan, GlaxoSmithKline, India Good cold chain infrastructure design Cold chain data management Clinical supply chain efficiency in emerging markets Nyoman Mahardika, Director, South Asia Supply Chain, Mead Johnson Nutrition, Thailand Ensuring subject safety and data quality through risk-based monitoring (RBM) Anticipating temperature excursions during regional transport through risk management strategy Javed Rashid, Chief Scientific Officer & Head, Medical (Pharmaceuticals), Novartis, Singapore Sanjit Singh Lamba, Managing Director, Eisai Pharmaceuticals, India Reserved for Merck Millipore Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com to explore speaking opportunities in these sessions Modular Packaging systems for smooth and cost saving operations Fabian Eschenbach, Head of Business Unit Thermal Packaging, va-Q-tec AG, Germany Roundtable discussions: Flip to page 14 to see the roundtable moderators Sanjay Desai, Director, Supply Chain, Thermo Fisher Scientific, Singapore Roundtable discussions: Flip to page 14 to see the roundtable moderators Table A: Pricing and reimbursement strategies in Japan, Korea and Australia Packaging your drugs for lucrative outlicensing deals Pradip M Patel, Vice President & Head – Vaccine (Operations & Project), Zydus Cadila, India Supply chain segmentation Industry update: Trends & challenges in supply chain logistics 12.20 Kathy Yu, Senior Director, Business Development and Strategy, Merck Serono, China Fostering biomedical innovation in emerging markets 15.30 CLINICAL DEVELOPMENT TRACK 4 15.50 Shakilla Shahjihan, Regional Director, Government Affairs, Asia-Pacific, Abbott, Singapore CELL CULTURE TRACK 3 Table A: In-licensing Table A: Process monitoring and statistical process control Table A: Applications of next-generation sequencing in clinical trials Table A: Creating an unbroken cold chain Table B: Out-licensing Table B: Continuous downstream processing Table B: Pan-Asian clinical trials coordination Table B: Human error in cold chain Table C: Technology transfer Table C: Emerging analytical technology and methods in support of biologics development & manufacturing Table C: Adaptive trials design Table C: Demand forecast for cost effective cold chain practices 16.50 Afternoon refreshments I Exhibition visit I 1-to-1 Partnering QUALITY BY DESIGN (QbD) 17.20 Access to innovation and technology for pharmas TRACK 2 17.40 11:40 11:20 11:00 MARKET ACCESS 13.20 Panel Discussion: Defining the capabilities and limits for single-use technology CLINICAL OPERATION Morning refreshments I Exhibition visit I 1-to-1 Partnering 18.00 TRACK 1 10:30 18.20 Speed networking - Sponsored by: Pete Gagnon, Senior Research Technology Specialist, Downstream Processing Group, Bioprocess Technology Institute, Agency for Science, Technology and Research (A*STAR), Singapore Key elements in structuring effective deals in China Making people’s lives better through change, innovation & growth 09:30 10:00 Jimmy Zhang, Vice President, Transaction, Asia Pacific, Johnson & Johnson Innovation Center, China Combating diseases with disruptive mRNA technology 09:00 DOWNSTREAM PROCESSING Analytical Quality by Design (AQbD) methods development using platform approach Jianmei Kochling, Director, Quality Science and Analytical Technology, Genzyme, USA Quality by Design (QbD) tools for pandemic influenza vaccine development Pradip M Patel, Vice President & Head, Vaccine (Operations & Project), Zydus Cadila, India Generation of variants in QbD James Sutter, BioProcess Sciences Downstream Process, Merck, Switzerland DATA MANAGEMENT No ELN is an Island Paul Whitehead, Head, pRED Informatics Center, Roche Pharmaceuticals, China Understanding translational medicine & global translational medicine situation Aamir Shahzad, President, European Society for Translational Medicine (EUSTM), Austria Translational development from pre-clinical to human Web-based crowdsourcing for clinical trials Jessie Gu, Head, Translational Medicine China, Novartis Institute for Biomedical Research, China Brand protecting approaches for pharmaceutical product serialization Translating imaging technology to discover and develop biomarkers Chih-Liang Chin, Director and Site Lead, Imaging, MSD, Singapore Pankaj Monga, Director, Brand Protection, Asia, Janssen, India Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com to explore speaking opportunities in these sessions 18.40 TRANSLATIONAL MEDICINE End of Conference Day 1 & BioPharma Awards Dinner 2015 Treating neurodevelopment disorder in children with translational medicine Afaf El-ansary, Professor, King Saud University, Saudi Arabia Premium conference Day Two 12:35 Wednesday 25 March 2015 Roundtable discussions: Flip to page 14 to see the roundtable moderators Table C: Regulatory approval for clinical trials in Singapore and Malaysia Table C: 3D printing technology for medical devices Table D: Implementing CLIA in clinical operations The end of copycat China 09:00 • The conventional role of China in the global pharma industry—Quantity over quality • Fostering innovation in China’s pharma market to break away from the copycat market • Introducing innovation to the market through new pharma partnership models Shaun Rein, Managing Director, China Market Research Group, China 13.35 The rise of creativity, innovation and individualism in Asia 09:45 VACCINES COMPLIANCE Advancing Asia’s biopharmaceuticals industry 14.30 TRACK 1 TRACK 2 TRACK 3 TRACK 4 Medical Device BIOSIMILARS REGULATIONS GENERICS Generating wealth in health: defining the real value of Asia’s healthcare market George Poole, Vice President, Managing Director, ASEAN, Medtronic International, Singapore Hearing from the big pharma: Pfizer’s perspective on development of biosimilars in Asia Ira Jacobs, Oncology Portfolio Global Medical Lead, Biosimilars, Pfizer, USA Reiko Yanagihara, Principal Reviewer, Division of Pharmacopoeia and Standards for Drugs Office of Standards and Guideline Development, Pharmaceutical and Medical Devices Agency (PMDA), Japan 14.50 Morning refreshments I Exhibition visit I 1-to-1 Partnering Global regulatory compliance of QbD strategies Panel discussion: Cashing-in on Asia’s promising biotechs Kiyean Nam, Chief Executive Officer, Qurient, South Korea Therapeutic vaccine development using a novel adjuvant Jung Sun Yum, Director, CHA Vaccine Institute, South Korea James Huang, Managing Partner, Kleiner Perkins Caufield Byers (KPCB), China Amit Kakar, Head, Healthcare, Asia, Avenue Capital Group, Hong Kong Innovative therapeutic vaccines Audits and inspections in Asia-Pacific Angeline Lau, Regional Manager, Clinical & Medical Quality Operations, Sanofi Pasteur, Singapore Aligning supply chain strategies with the EU GDP and China’s GSP regulations Michael Lee, Vice President, Operations, Lohmann, Taiwan Academic’s priorities in industrial collaboration Innovating generics marketing: Teva’s perspective 15.10 11.15 Networking luncheon I Exhibition visit I 1-to-1 Partnering PARTNERING MODELS • The historical tsunami—Rising significance of Asian markets and emerging Asian pharmas • Business growth opportunities for global and Asian pharmas in Asia • Strategies to exploit growth market in Asia Christopher Gallen, President, SK Biopharmaceuticals, Korea Transforming a spin-off to seize the global marketplace 10:30 Table C: Generics manufacturing quality control Table C: Biosimilars and biobetters development Erez Hybloom, Senior Director, Head, Supply Chain, Teva Japan & Korea, Teva Pharmaceuticals, Israel Michael Rossbach, Head, Strategic Alliances, Business Development & Scientific Programme Management, Genome Institute of Singapore, Singapore Novel adjuvants for effective vaccine development Balancing costs and quality in packaging Cedric Dubois, Head, China Industrial Operations, Sanofi Pasteur, China CELL / GENE THERAPY Ex-vivo expanded allogenic natural killer cell for cancer therapy Yu Kyeong Hwang, Director, Cell Therapy Research Centre, Green Cross, LabCell, KIorea Combating cancer through early diagnosis and targeted therapy: a case study of human hepatocellular carcinoma (HCC) Kam Man Hui, Deputy Group Director, Research, SingHealth, Singapore Development of Wnt pathway inhibitors for cancer therapy David Marc Virshup, Professor and Director, Cancer and Stem Cell Biology, Duke-NUS, Singapore Anthony Wilkinson, General Manager, Asia Pacific & Medical Director, Cook Medical, Hong Kong Risks management for medtech investments in Asia Sashi Kumar, Founder & Managing Director, Phoenix Medical Systems, India Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com to explore speaking opportunities in these sessions Global biosimilars regulatory compliance Pharmacovigilance of Biosimilars Sreedhar Sagi, Head, Medical Affairs, Asia-Pacific, Sandoz, Singapore Generics formulation and manufacturing Victoria Elegant, Vice President, Medical, Clinical, Regulatory Affairs, Baxter International, China Chongdeok Park, COO, Head, R&D, JinYang Pharmaceuticals, South Korea IND submission and approval in Japan Limiting competitions in generics market to secure a good Koike Satoshi, Director, Regulatory Affairs, Japan, Amgen Astellas Biopharma KK, Japan Generic drug user fee amendment Reserved for Catalent Bobby George, Vice President and Head, Regulatory Affairs, Reliance Life Sciences, India Table A: Regulatory approval for clinical trials in Japan, Korea and Australia Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com to explore speaking opportunities in these sessions Table A: Risk assessment & exit strategies for biotech investors Table A: Vaccine access for developing nations Table A: Best GDP practices in Asia Table A: Embryonic stem cells research and applications Table B: Capital raising strategies for biotech start-ups Table B: Single use-technology in vaccines manufacturing Table B: Best GMP practices in Asia Table B: Cell therapy for cancer treatment Table C: Public private partnerships Table C: Patient recruitment & retention for vaccines trials Table C: Best GCP practices in Asia Table C: Challenges in commercializing Stem Cell products in India and SEA Patent expiry of generics Leena Menghaney, Head, Access Campaign, South Asia, Doctors without Borders/Medecins Sans Frontieres, India Table A: Innovative R&D for generics 12:35 Table A: Translating biosimilar market trends into sound production strategies Elena Rizova, Vice President External Innovation, Johnson & Johnson Innovation Center, China Roundtable discussions: Flip to page 14 to see the roundtable moderators Nicola Travierso, General Manager, NTC Pharma, Italy Roundtable discussions: Flip to page 14 to see the roundtable moderators Table A: End-to-end design & development of medical devices 15.30 Regulatory updates for trials in Asia 15:50 12.15 11.55 11.35 Accessing external innovation in Asia Setting up shop in Asia: evaluating market opportunities for medical devices in Asia Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com to explore speaking opportunities in these sessions Table B: Performing Health Technology Assessment (HTA) for medical devices Table B: Regulatory requirements for biosimilars manufacturing Table B: Regulatory approval for clinical trials in China and India Table B: Marketing & distribution initiatives for generics 16.50 Afternoon refreshments I Exhibition visit I 1-to-1 Partnering 17.30 End of conference Table D: Stem cell in drug development and discovery Roundtable discussions Roundtable discussions Day 2: Pick one roundtable session from this timeslot Roundtable discussions are available for premium pass conference holders. You can choose a roundtable in each of the different time slots. Popular topics tend to fill up quickly, so we suggest you book your ticket early! Table A: End-to-end design & development of medical devices Guna Sekaran, Deputy General Manager & CoE Head, Cyient, India Roundtable discussions Day 1: Pick one roundtable session from this timeslot Day 1, 12:20 – 13:20 Pricing and reimbursement strategies in Japan, Korea and Australia Table B: Pricing and reimbursement strategies in China and India Silver Chen, Senior Director, Regional Access Lead, Asia-Pacific, Pfizer, Hong Kong Table C: Pricing and reimbursement strategies in Singapore & Malaysia Nathan Kothandaraman, Director, Market Access & Government Affairs, Janssen, Malaysia Table A: Hybrid manufacturing for cell culture production Amol Kataria, Research Associate, Intas Pharmaceuticals Limited, India & Barbara Paldus, Chief Executive Officer, Finesse, USA Table B: Raw material testing & handling Swapnil Ballal, Senior Director, Quality Assurance, Biocon, India Table C: Table A: Customizing your embedded clinical development strategy Karen Young, Associate Director, Embedded Clinical Programs, Strategic Solutions, PRA Health Sciences, Australia Clinical outsourcing models in China and India Jeroze Dalal, General Manager, Clinical Operations, GlaxoSmithKline, India Ken Pennline, Vice President, Global Head, Cytometry Services, Labcorp, USA Table C: Clinical outsourcing models in Singapore & Malaysia Cellular immunotherapy manufacturing facilities Reverse logistics Rajesh Pednekar, Head, Distribution Pfizer, India Jonathan Newton, Regional Senior Director, Clinical Operations (Asia Pac), PRA Health Sciences, Singapore Table B: Yee Leong Teoh, Chief Executive Officer, Singapore Clinical Research Institute (SCRI), Singapore Table B: Managing 3PLs in a complicated supply chain network In-licensing Process monitoring and statistical process control Kathy Yu, Senior Director, Business Development and Strategy, Merck Serono, China Pankaj Gour, Downstream expert MS&T, Novartis BiopharmOps, Singapore Table B: Table B: Table A: Applications of next generation sequencing in clinical trials Matthew Moore, Ph.D Principal & co-founder, ResearchDx, USA Table B: Nilesh Wadhwa, Regional Director, Business Development & Strategy, Takeda Pharmaceuticals, Singapore Table C: Technology transfer Swapnil Ballal, Senior Director, Quality Assurance, Biocon, India Table C: Table D: Aseptic fill and finish process Ramesh Kashi, Senior Principal Scientist, Merck, USA Kensei Tsuzaka, Chief Executive Officer, Kaytee Bio, Japan Table C: Pankaj Monga, Director, Brand Protection, Asia, Janssen, India Julien Zhao, Manager , Asia Biosimilar & Emerging Biotech Markets, Process Solutions, Merck Millipore, China Koike Satoshi, Director, Regulatory Affairs, Japan, Amgen Astellas Biopharma KK, Japan Bobby George, Vice President and Head, Regulatory Affairs, Reliance Life Sciences, India Table B: Table B: Table B: Regulatory approval for clinical trials in China and India Marketing & distribution initiatives for generics Karen Wen, Chief Executive Officer, Mycenax Biotech, Taiwan Victoria Elegant, Vice President, Medical, Clinical, Regulatory Affairs, Baxter International, China & Erez Hybloom, Senior Director, Head, Supply Chain, Japan & Korea, Teva Pharmaceuticals, Israel Table C: Table C: Regulatory requirements for biosimilars manufacturing Laurent Rebier, Director, Business Development, Biosimilars, Merck Serono, Switzerland Nicola Travierso, General Manager, NTC Pharma, Italy Table C: Shun Jin, Director, Regulatory Policy & Intelligence, Japan – Asia-Pacific, Abbvie, Singapore Generics manufacturing quality control Table D: Implementing CLIA in clinical operations. Philip D Cotter, Prinicpal & Cofounder, Research Dx, USA Table C: Improving clinical supply importation and exportation Pick one roundtable session from this timeslot Edwin Sia, Associate Director, Logistics, Asia Pacific, Quintiles, Singapore Table A: Table A: Table A: Table A: Embryonic stem cells research and applications Risk assessment & exit strategies for biotech investors James Huang, Managing Partner, Kleiner Perkins Caufield Byers (KPCB), China Table A: Best GDP practices in Asia Vaccine access for developing nations Sanjay Desai, Director, Supply Chain, ThermoFisher Scientific, Singapore Aamir Shahzad, President, European Society for Translational Medicine (EUSTM), Austria Table B: Creating an unbroken cold chain Table B: Pan-Asian clinical trials coordination Human error in cold chain Karen Wai, Senior Director, ISS, Head, Site Services, Quintiles, Singapore Shirley Xu, Head, Site Supply, Novartis Vaccines, China Table B: Capital raising strategies for biotech start-ups Kiyean Nam, Chief Executive Officer, Qurient, South Korea Table C: Table C: Translating biosimilar market trends into sound production strategies Regulatory approval for clinical trials in Singapore and Malaysia Min Yuan Seow, Regional Supply Chain Manager, Greater Asia Region, Becton Dickinson, Singapore Emerging analytical technology and methods in support of biologics development & manufacturing Jianmei Kochling, Director, Quality Science and Analytical Technology, Genzyme, USA Performing Health Technology Assessment (HTA) for medical devices Branding strategies in the competitive medical device industry Continuous downstream processing Out-licensing Table B: Shirley Xu, Head, Site Supply, Novartis Vaccines, China Day 2, 15:50 – 16:50 Day 1, 15:50 – 16:50 Table A: Table A: Guidance and regulations of generics product Partnering in Biosimilar development Pick one roundtable session from this timeslot Table A: Table A: Regulatory approval for clinical trials in Japan, Korea and Australia Table A: Day 2, 12.35 – 13.35 Table A: Table A: Table B: Table B: Yu Kyeong Hwang, Director, Cell Therapy Research Center, Green Cross LabCell, South Korea Single use-technology in vaccines manufacturing Jim Miller, Vice President & Head, Biologics Drug Substance Manufacturing Network, Genentech, USA Table C: Cell Therapy for cancer treatment Best GMP practices in Asia Table C: Challenges in commercializing Stem Cell products in India and SEA Table C: Table C: B.N. Manohar, Managing Director & Chief Executive Officer, Stempeutics Research, India Table D: Adaptive trials design Hye Jin Choi, Senior Director, Regulatory Affairs, & Study StartUp, Asia-Pacific, ICON Clinical Research, South Korea Demand forecast for cost effective cold chain practices Sagnik Sengupta, General Manager, Distribution, Bharat Serums and Vaccines, India Public private partnerships Tom Geimer, Managing Director, Madeline Pharmaceuticals, Australia Patient recruitment & retention for vaccines trials Best GCP practices in Asia Challenges in commercializing Stem Cell products in India and SEA Manjunath Ramarao, Director, Head, Disease Sciences and Technology, Bristol Myers-Squibb, India Workshops Purchase a 3 day pass and you can join two workshops on 23 March 2015. The workshops will be in small groups, led by an industry expert giving you the chance to meet other professionals working in a similar field and get an in-depth understanding of the topics. Choose one from the morning and one from the afternoon. Go to the biopharma website to see up to date workshop agendas and leaders. Morning: Afternoon: Designing innovative clinical trials • Learn how to eliminate failures in trials by focusing on the details in clinical trial design • Move away from copy-the-last protocols and high-variance designs Pricing strategies for biopharmaceuticals in Best practices in cold chain management in Asia • Learn how to manage temperature in biologic storage and transportation • Optimise product integrity of biological products at low cost and high efficiency Creating sustainable biomanufacturing plant with single use technologies • Learn how to use the latest tools to implementing single use technology in existing plants • Learn strategies to streamline the manufacturing process using single use technology Positioning your R&D pipelines as an attractive investment • How best to package your pipelines to get a lucrative deal • Learn how to maximize your share in the global market as an Asian biotech. emerging markets • Learn sound pricing strategies to commercialise your blockbuster drugs in Asia’s emerging markets. • How to stress value to make your drug appealing to an emerging market Networking We’ve created ample opportunities for you to network with the other attendees at the BioPharma Asia Convention; many of them are included in the premium conference agenda, but you can join us at these additional activities as well. 1-2-1 Partnering Participate in the speed networking sessions to put faces to names and arrange follow ups. On site, we have meeting room facilities for you to host private business meetings. Remember, if you can’t catch someone on site, you can use the app to send messages and meeting requests. Welcome Cocktail Reception Achieving excellence in biologic manufacturing with continuous improvement • Learn about the adoption of QbD in biomanufacturing as well as other operation excellence strategies which can be applied in creating efficient biologic manufacturing process • Learn how to motivate employees, streamline manufacturing processes and minimise production waste Clinical trials outsourcing in Asia • Learn how to select your partners, domestic/ regional CROs with the right specialisations • Successfully manage a mutually beneficial relationship with your CROs and local counterparts Using big data analysis to streamline supply chain practices • How to use big data to enhance supply chain efficiency and minimise waste • Learn more on optimising supply chain operations to minimising cost and maximize profit If you think you’re an expert in any of these fields and want to lead a workshop, contact Kenneth today at +65 6322 2792 or Kenneth.lai@terrapinn.com To join these workshops, book your 3 day pass online now at www.terrapinn.com/biopharma or call +65 6322 2701 Network with the other attendees over a complimentary cocktail. Get to know the delegates you’ll be spending the next couple of days with and make some initial introductions. This is open to all premium conference pass holders. RSVP required 23 March, 7.00pm – 8.30pm, Secret venue (confirmed upon registration) Networking app Download the networking app to get organised and get in touch with all attendees months before the event begins Use the app: • Plan your sessions • Build a personalised agenda • Identify exhibitors to visit • Set up onsite meetings with key executives • Network with other attendees Keep your messages, meeting schedules and session agenda at your fingertips. You can continue to use this networking tool for a full year after the event so you can follow up with anybody you missed months down the line. Contact us today on +65 6322 2770 to confirm your attendance at these networking activities and purchase premium conference passes Who’s attending Benitec Chief Executive Officer Australia Dimerix Bioscience Pty Non Executive Director And Former Chief Executive Officer Australia HepSeeVax Managing Director Australia Imugene Exeuctive Director Australia Mariposa Health Managing Director Australia Pfizer Australia Pty Senior Director and Head, External R&D Innovation, Australia, New Zealand and Singapore Australia Starpharma Chief Executive Officer Australia E.U.S.T.M. President Austria Baxter International Vice President, Medical, Clinical, Regulatory Affairs China Bayer Healthcare Global Regulatory Strategist China Beijing Minhai Biotech Vice President R&D China CANbridge Life Sciences Chief Executive Officer China China Market Research Group Managing Director China Covance Senior Clinical & Ancillary Supplies Manager, Asia Pacific China Gproan Protein Engineering Chief Executive Officer China HuaBo Biopharm Co-Founder and Chief Executive Officer China Huaota Biopharm Chief Executive Officer China Immuon Therapeutics Chief Executive Officer China Kanghong Sagent (Chengdu) Pharmaceutical Chief Executive Officer China KBP Biosciences Senior. Vice President of Clinical Research and Chief Medical Officer China KBP Biosciences Founder, President, Chairman China KBP Biosciences Vice President, Pharmacology China Kleiner Perkins Caufield and Byers Managing Partner China Lingmed Business Development Manager China Merck Serono Senior Director, Business Development & Strategy China NeuPharma Chief Executive Officer China Novartis Head, Site Supply China Novasep Sales Director China Roche Senior Automation Engineer China Roche Unit Lead, Manufacturing IT China Sanofi Associate Director, Unit Strategy Officer, Asia Pacific TSU China Sanofi Pasteur Head of China Industrial Operations China Sotio Chief Operating Officer China Suzhou Connect Biopharmaceuticals Chief Executive Officer China Tarrex Biopharma Chief Operating Officer China Yisheng Biopharma Chief Financial Officer China Merck Serono Business Development Manager Peoples Republic Of China Merck Serono Business Development Director Peoples Republic Of China Novartis China Head, Translational Medicine China Peoples Republic Of China Techpool Bio Pharma Plant Director Peoples Republic Of China va-Q-tec Ag Chief Engineer and Business Unit Manager, Thermal Packaging Germany Vetter Pharma International GmbH Vice President Germany Vetter Pharma International GmbH Director, Business Development Asia Germany Txcell Venture Partner Germany Colder Products Company Marketing and Customer Service Manager Hong Kong ICON Clinical Research Marketing Manager, APAC Hong Kong MabSpace Biosciences Chief Executive Officer Hong Kong Pfizer Senior Director, Regional Access Lead Asia-Pacific/China Hong Kong Biocon Senior Manager and Head, Biosimilars International Regulatory Affairs India Biocon Head, Quality Assurance - Biologics India Biological E Associate Director India Eisai Managing Director India GlaxoSmithKline Head Clinical Operations India GlaxoSmithKline General Manager, Clinical Operations, India & Pakistan India Indchemie Health Specialities Pvt. Ltd General Manager, Distribution India Indus Biotech Managing Director India Intas Biopharmaceuticals Research Associate, Cell Line Development India Invictus Oncology Associate Director - R&D India Johnson & Johnson Director, Brand Protection, Asia India Lambda Therapeutic Research Limited AVP, Business Development India Doctors Without Borders Head Access, South Asia India Novalead Pharma Vice President, R&D India Novartis Associate Clinical Distribution Manager India Pfizer Head Distribution India PLUSS Director Business Development India Sun Pharmaceuticals Head Supply Chain India Takeda Pharmaceuticals Regional Director Business Development & Strategy India West Coast Pharmaceutical Works Managing Director India Wockhardt Limited Associate Vice President and Head Legal India Zydus Cadila Vice President and Head Vaccine Manufacturing India Stem Cell and Cancer Institute Manager R&D Indonesia Stem Cell and Cancer Institute Principal Investigator Indonesia Galmed Pharmaceuticals Chief Executive Officer Israel Pluristem Chairman and Chief Executive Officer Israel Amgen Astellas BioPharma KK Director, Regulatory Affairs Japan Kaytee Bio Chief Executive Officer Japan Morunda K.K. Representative Director Japan Pharmaceutical and Medical Device Agency PMDA Principal Reviewer Japan Clinical Investigation Centre, University of Malaya Head Research Unit Malaysia Clinical Research Malaysia Director Malaysia Eli Lilly ASEAN Medical Director Malaysia Janssen Director, Market Access & Government Affairs Malaysia Sentinext Therapeutics Chief Executive Officer Malaysia European Patent Office Patent Examiner Netherlands Sinensis Life Sciences BV Chief Business Officer Netherlands Viroclinics Biosciences B.V Marketing and Communication Officer Netherlands Curonz Chief Scientific Officer New Zealand Alteogen Chief Executive Officer Republic Of Korea Qurient (formerly Quro Science) Chief Executive Officer Republic Of Korea S.K. Biopharmaceuticals Chief Executive Officer Republic Of Korea TransPerfect Account manager Republic Of Korea King Saud University Professor Saudi Arabia Abbott Regional Director, Government Affairs, Asia Pacific Singapore Abbott Nutrition Research & Development Clinical Project Manager Singapore Abbott Nutrition Research & Development Director, Clinical Research Singapore AbbVie Site Manager Singapore AbbVie Medical Director, South Asia Singapore AbbVie Regional Medical Operations Manager Japan, APAC Singapore Aik Moh Paints & Chemicals Business unit head Singapore Asia Cold Chain Centre Chief Executive Officer and Principal Consultant Singapore Astellas Pharma RA QA & PV Manager Singapore Austrianova Singapore Head Research and Development Singapore B.T.I Staff Scientist, Animal Cell Technology Singapore Baxter Senior manager Planning & Deployment Singapore Baxter Bioscience Head Manufacturing Singapore Baxter BioScience Manufacturing SARL Manufacturing Engineer Singapore Baxter Bioscience Manufacturing SARL Process Engineer Singapore Baxter Healthcare Asia Senior Manager Operations and Compliance Singapore Bayer Senior Regulatory Affairs Associate Singapore Bayer Head Supply Coordination Asia Pacific Singapore Bioprocessing Technology Institute Senior Research Technology Specialist Singapore Bioprocessing Technology Institute Research Officer Singapore Bioprocessing Technology Institute Research Scientist Singapore Boehringer Ingelheim Clinical Operations Quality Manager Singapore Boehringer Ingelheim Regional Clinical Operations Therapeutic Area Leader Singapore Celgene Associate Manager, Logistics & Supply Chain Singapore Ciba Vision Head Procurement Singapore Who’s attending Clearbridge Accelerator Senior Investment Manager Singapore Prime Biologics Director Regulatory Affairs and Quality Assurance Singapore ClinActis Chief Executive Officer Singapore PSS Manager Singapore Clinical Imaging Research Centre Quality Assurance Manager Singapore Quintiles Associate Director Logistics Singapore Dr. Reddy's Laboratories Global Head, Technical Operations & CEO, Singapore Operations Singapore Sanofi Head, Unit Development Operations, Asia R&D Singapore Duke NUS Program Director, Cancer Stem Cell & Biology Singapore Sanofi Director of Operation, Asia-Pacific R & D Singapore Eli Lilly & Company Quality Auditor Singapore Sanofi Pasteur Regional Manager, Clinical & Medical Quality Operations Singapore Eli Lilly & Company QA Consultant Singapore Sanofi Pasteur Regional Clinical Trial Manager Singapore Eli Lilly & Company Lead Consultant, Global Medical Quality Singapore SDV Logistics Quality Assurance Executive, Pharmacist Singapore ELPRO-BUCHS AG Market Research Manager Singapore Servier Regulatory Affairs Manager Singapore GlaxoSmithKline Vice President Singapore Shire Regional Medical Lead, Internal Medicine Singapore Genome Institute of Singapore Manager, Strategic Alliances Singapore Singapore Clinical Research Institute Chief Executive Officer Singapore Genzyme Senior Director & Regional Medical Officer, Japan - Asia-Pacific Singapore Singapore Clinical Research Institute Chief Medical Officer Singapore Genzyme Regional Regulatory Affairs Manager Singapore Singapore Clinical Research Institute Head, Project Management Singapore Glaxo Wellcome Manufacturing Head of external ventures Singapore Singapore Immunology Network (SIgN) Principal Investigato Singapore GlaxoSmithKline Director Emerging Markets, R&D Singapore Sirtex Regional Medical Director, Asia Pacific Singapore Global Airfreight International Senior Executive Singapore Taiho Pharma Medical Affairs Manager Singapore GlaxoSmithKline Chemical Engineer, Manufacturing Singapore Taiho Pharma Clincal Research Manager Singapore Hays Life Sciences Consultant Singapore Takeda Development Center Asia Regional Head, Regulatory Affairs Singapore Hospira QA Manager, SEA/HK Singapore Takeda Development Center Associate Director, Clinical Operations, Asia Therapeutic Area Lead Singapore HSBC Institutional Trust Services (Singapore) Marketing Manager Singapore Takeda Development Centre Clinical Study Manager Singapore Institute of Bioengineering and Nanotechnology Principal Research Scientist Singapore Takeda Pharmaceuticals Regional Director, Business Development and Strategy Singapore Institute of Materials Research and Engineering Scientist Singapore Takeda Vaccines Senior Scientist Singapore Institute of Medical Biology, A*STAR Strategic Alliances Manager Singapore Teva Pharmaceutical Investments Regional Regulatory Affairs Manager (APAC) Singapore Institute of Medical Biology, A*STAR Project Manager Singapore Thermo Fisher Scientific Director Supply Chain Asia Singapore InVivos Pte Ltd Business Development Manager Singapore UCL Medical Representative Singapore Johnson & Johnson Regional Regulatory Affairs Director Singapore Debiopharm International S.A. Associate Director Head of Licensing Switzerland Johnson and Johnson Consumers Asia Pacific External Manufacturing ? Source Singapore Haselmeier GmBH Sales Assistant Switzerland Lilly-NUS Managing Director Singapore Development Center for Biotechnology Director, CGMP BPPF Taiwan Lonza Biologics Technical Investigator Singapore Lohmann Vice President, Operations Taiwan Lonza Biologics Purification Scientist Singapore Mead Johnson Nutrition Director, South Asia Supply Chain Thailand Lonza Biologics Process Engineer Singapore RitzCarlton Auditor United Arab Emirates Lonza Biologics Senior Section Lead (MSAT) Singapore Barrington James Director United Kingdom Merck Sharp & Dohme Director, Supply Chain Management Singapore Dotmatics Head - Enterprise Partnering United Kingdom MerckGroup Distribution Manager - Chemicals Singapore Avenue Capital Group LLC Head, Healthcare, Asia United States Metrohm Singapore Chief Sales Officer (Europe), Spectroscopy Group Singapore Catalent Pharma Solutions Tradeshow United States Metrohm Singapore Managing Director Singapore eResearchTechnology Inc Senior Vice - President - Asia - Pacific United States Morgan McKinley Consultant Singapore Finesse Solutions, LLC Asia Pacific Sales Manager United States Merck Sharp & Dohme/ Translation Medicine Research Centre Director and Site Lead, Imaging Singapore Genentech Vice President and Head, Biologics Drug Substance Manufacturing Network United States Mundipharma Manager, Regulatory Affairs, Asia Singapore Genentech Director of Manufacturing Operations United States National Cancer Centre Singapore SingHealth Deputy Group Director, Research Singapore Johnson & Johnson Vice President of Transactions United States National University of Singapore Student Singapore Johnson & Johnson Vice President, Transactions, Asia-Pacific United States Novartis Senior Expert Infrastructure and HVAC Site Services Singapore KBI Biopharma Vice President, Business Development United States Novartis Downstream Expert - MS and T Singapore LabCorp Marketing Manager United States Novartis Institute for Tropical Diseases Investigator III Singapore Marken Global Director for Direct to Patient Services United States Novartis Oncology Chief Scientific Officer and Head of Medical (Pharma Division) Singapore Marken Vice President Commercial Operations Asia Pacific United States Novartis Head, Site Engineering, Biopharm Operations Singapore MN Thermal Science Marketing Communications Director United States Novartis Site Quality Head BiopharmOps Singapore Singapore Moderna Therapeutics President & Founding Chief Executive Officer United States Novartis Project Director Singapore Pfizer Oncology Portfolio Global Medical Lead-Biosimilars United States Novartis Process Specialist MS&T Singapore Quintiles Director of Global Marketing United States Novartis Downstream Technician Singapore ResearchDx Principal United States NUHS Tissue Repository Medical Technologist Singapore S.G. Research International President United States National University of Singapore Research Assistant Singapore Sanofi Pasteur Deputy Director, Mtech/AP&T - Extractables & Leachables United States Parker domnick hunter Technical Support Engineer Singapore SNBL USA Director of Business Development - APAC United States Pfizer Senior Supply Chain Specialist Singapore Toyota Director, Strategic Insight & Innovation United States Pfizer Supply Chain Specialist Singapore Bayer HealthCare Country Head and Bayer HealthCare Representative Vietnam PrIME Biologics Manager, IT and Facilities Singapore International Air Transport Association Regional Head, APCS Freemium conference Day One Theatre One Theatre Two Asian Biotech Theatre Clinical trials in stem cells & regenerative medicines Suzhou Connect Biopharmaceuticals, China Tuesday 24 March 2015 Zheng Wei, Chief Executive Officer 3.20 Clinical trials for diabetes Prevalent diseases in Asia Theatre One Theatre Two Asian Biotech Theatre 3.40 Clinical trials for degenerative neurology Galmed, Israel Allen Baharaff, Chief Executive Officer Facility & process design 11.00 Vaccines Man or machine? The balance between company’s money and morale David Lawrence, Chief Executive Officer Best facility designs for aseptic Biomanufacturing HepSeeVax, Australia Barbara Paldus, CEO, Finesse, USA Serina Cucuzza, Managing Director Statistical process monitoring in biosimilar production Pankaj Gour, Downstream expert MS&T, Novartis Biopharm Ops, Singapore 12.20 Vijay Nag Thota, Head, Analytical Quality & Regulatory, SciGen BioPharma, India Clinical trials on stem cell therapies for heart disease 4.40 Clinical trials on stem cell therapies for ultra rare diseases CuroNZ, New Zealand Frank Sieg, Chief Scientific Officer Kaytee Bio, Japan Kensei Tsuzaka, Chief Executive Officer Sentinext Therapeutics, Malaysia Jogesh Bhole, Senior Expert, Infrastructure & HVAC-Site Services, Novartis, Singapore 12.00 4.20 Wei Wenjin, Vice President, R&D HVAC in good clean room design 11.40 Clinical trials for rheumatoid arthritis Beijing Minhai Biotechnology, China Rajnish Narula, Production Director, Pfizer, Singapore 11.20 4.00 Research symposium hosted by: Japan Analytical Instruments Manufacturers Association Chengdu Kanghong Pharmaceuticals, China Chen Su, Chief Executive Officer Pluristem, Israel 5.00 Zami Aberman, Chief Executive Officer ImmuOn Therapeutics, China End of day one John Wang, Chief Executive Officer Continuous process verification Imugene, Australia Nick Ede, Managing Director Manufacturing Technologies 12.40 1.00 1.20 Optimising tangential flow filtration unit operations Adopting micro carriers to grow cells in suspension culture Qualitative high throughput analytics to support polysaccharide biologic production Freemium conference Yisheng Biopharma, China Day Two David Shao, Chief Financial Officer Analytical diagnostics Forum hosted by: Japan Analytical Instruments Manufacturers Association Gproan Protein Engineering, China Wednesday 25 March 2015 Haiqian An, Chief Executive Officer MabSpace Biosciences, China Xueming Qian, Chief Executive Officer Theatre One Theatre Two Asian Biotech Theatre Chronic Diseases Clinical trials in Oncology 1.40 Disruptive technology-an alternative to protein A for mabs production Clinical trials for lung cancer Research symposium Hosted by: Singapore Immnunology Network (SIgN), Singapore Clinical trials for chronic myeloid leukemia Visit the website for updated information on this session KBP Biosciences, China Long Li, Vice President of Pharmacology 9.00 Quality Control 2.00 Implementing Total quality management (TQM) in pharma manufacturing process Anjali Mahajan, Manager, Biocon, India 9.20 Novalead Pharma, India Advanced flow cytometry applications Optimising the manufacturing process with lean 6 Sankar Dharmaraj, Senior Manager-Quality Leadership Process Operation Excellence, Baxter Bioscience, Singapore Mariposa Health, Australia Phillip Comans, Managing Director 10.00 Raw Material Identification in less than 30 seconds 2.40 3.00 Indus Biotech, India Wim Guns, Chief Sales Officer, Spectroscopy Group, Metrohm-NIRSystems, Singapore Sunil Bhaskaran, Managing Director Best facility for real time process monitoring Neuclone, Australia Bo Zhu, Senior Process Automation Engineer, Roche, China Noelle Sunstrom, Chief Executive Officer Reserved for Quintiles Benitec Biopharma, Australia Peter French, Chief Executive Officer Huabo Biopharm, China Wenzhi Tian, Chief Executive Officer Chikungunya virus infection Sudhir Kulkarni, Vice President, R&D 9.40 2.20 Oncology Ken Pennline, Ph.D, Vice President & Global Head, Cytometry Services, Labcorp, USA Patent protection for personalized medicine in Europe using PCT procedure Fredrik Aslund, Patent Examiner, European Patent Office, The Netherlands Lisa Fong Poh Ng, Principal Investigator Invictus Oncology, India Monideepa Roy, Vice President, R&D Hepatitis B virus infection Ren Ee Chee, Principal Investigator CANBridge Life Sciences, China James Xue, Chief Executive Officer Clinical trials in vaccines 10.20 Clinical trials for Malaria Vaccines Qurient Therapeutics, Korea Yisheng Biopharma, China Kiyean Nam, Chief Executive Officer Freemium conference Day Two Wednesday 25 March 2015 Theatre One 10.40 11.00 Theatre Two Asian Biotech Theatre Clinical trials for Influenza Vaccines Dengue virus infection Tarrex Biopharma, China Reserved for Viroclinics Katja Fink, Principal Investigator Kanyin Zhang, Chief Executive Officer Clinical trials for hepatitis B vaccines Reserved for CIC University of Malaya Mycobacterium tuberculosis infection Amit Singhal, Project Leader 11.20 Clinical trials for HIV Vaccines Tuesday, 24 March, 2015; 09:00-09:30am NeuPharma, China Warehousing & product distribution Best practices in stock handling 12.00 Medigen Biotechnology, Taiwan Sagnik Sengupta, General Manager, Distribution, Bharat Serums and Vaccines, India David Ma, Director, Business Development Cold chain transportation in tropical countries TTY Biopharm, Taiwan Michael Lee, Vice President, Operations, Lohmann, Taiwan Lily Lien, Associate Project Manager Selecting the right 3PL in cold chain logistic 12.20 Alteogen, Korea Sanjay Desai, Supply Chain Director, Thermo Fisher Scientific, Singapore Soon Jae Park, Chief Executive Officer Raw material procurement in India 12.40 Bora Pharmaceuticals, Taiwan Sanjit Singh Lamba, Managing Director, Eisai Pharmaceuticals, India Bobby Sheng, Chairman Product integrity and supply chain security Starpharma, Australia Biopharmaceutical supply chain sustainability in Asia 1.00 Au Yang Sian, Senior Manager Planning & Deployment, Asia Pacific, Baxter International, Singapore 1.20 Handling emergency cases when product integrity is compromised due to mishandling 1.40 Shipment security: Marine & Air transportation 2.00 Outsourcing decision: warehousing activities and inventory management 2.20 Smart Packaging 2.40 Product integrity during warehouse storage 3.00 End of Day Two Jackie Fairley, Chief Executive Officer Research symposium hosted by: Stem Cells & Cancer Institute, Indonesia President & Founding Chief Executive Officer, Moderna Therapeutics, USA Akiko Itai, Chief Executive Officer Shawn Qian, Chief Executive Officer 11.40 Stephan Bancel IMMD, Japan Fungal infection Norman Pavelka, Principal Investigator “MODERNA IS A QUANTUM CHANGE.” Listed as one of CNBC’s Disruptor 50 due to their novel drug applications, mRNA Therapeutics, Moderna Therapeutics is revolutionising the biotech world by allowing patients to build their own drugs. The BioPharma Asia Convention is the most important pharma conference in Asia year by year. CELGENE The BioPharma Asia Industry Awards “NOTHING IS EVER TOO IMPORTANT TO FAIL” Innovate. Impact. Inspire. The 5th Biopharma Asia Industry Awards dinner celebrates 10 organisations/individuals for their contributions and achievements to Asia’s burgeoning biologics industry. David Gallon Join over 250 biopharma a-listers at this year’s BioPharma Asia industry awards evening, which promises to be a starry affair indeed. ve ati ov ch n In ote Bi Director, Strategic Insight & Innovation, Toyota Financial Services, USA O ng i s ni g co he e t R st e B Asia Mal n Exe e c an Asi an m o W ec Ex Up So str lu eam tio n Pharma Tuesday, 24 March, 2015; 09:30-10:00 am CR CMO LS P ld Co ain Ch am tre ns ion w Do olut S STEP 1: Vote online for the nominees at www.terrapinn.com/bio-asia/awards STEP 2: Book your ticket for the ceremony online today at www.terrapinn.com/biopharmaasia 7.00pm – 9.30pm, 24 March 2015, Suntec Singapore Convention & Exhibition Centre Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com www.terrapinn.com/bio-asia/awards For years, David has been consulting the automotive industry on how to adopt innovation by spotting social trends. To the pharma industry, where a single product can take years of research and billions of costs, he encourages high risk appetite and openness to failure and change. Get involved Be seen & heard The Exhibition • Be seen as an initiator in BioPharma innovation. • Secure your booth along the busy aisles to generate maximum traffic • Take the stage to showcase your expertise in front of a pool of prospects • Present a case study at the pharma value chain development seminars • Share your latest products and services to an exhibition full of potential customers NETWORKING LUNCHEON & REFRESHMENTS PREMIUM TRACK 4 • Network! Rub shoulders with warm leads and key clients across Asia • Secure a speaking slot in front of a receptive audience of senior level decision makers in the premium conference • Pre-arrange 1-2-1 meetings with your preferred client list Who you will meet COUNTRY PAVILLION C30 A27 A28 B27 A25 A26 B25 A23 A24 B23 MR6 MR7 C28 FREEMIUM THEATRE 1 PREMIUM TRACK 1 FREEMIUM THEATRE 2 C26 COUNTRY PAVILLION MR8 B20 MR5 C21 NETWORKING LOUNGE MR4 MR3 MR2 B16 C17 B14 C15 MR1 GENIE BAR ASIAN BIOTECH SHOWCASE F20 G21 F18 G19 F16 G17 F14 G15 Who should sponsor & exhibit • Contract service providers (CROs, CMOs, CDMOs) • CXOs from APAC biopharma brands LOUNGE • CXOs from biotechs and SMEs • Decision makers across the APAC biopharma value chain PREMIUM TRACK 3 B08 C09 D12 C10 D11 D10 E09 E07 E10 F11 F10 G11 E08 F07 F08 G07 • Clinical research solution providers PREMIUM TRACK 2 G08 C08 D07 D08 C04 D05 D04 E04 F05 F04 F05 G04 D02 E02 E03 F02 F03 G02 • Directors of the various biopharma verticals B02 • Decision influencers and industry stakeholders of the APAC Biopharma Industry SOLD RESERVED C02 • Host private luncheons, cocktails, seminars with your pre-qualified guest list • Lead roundtable discussions that show off your expertise and industry knowledge F24 C24 B18 • CXOs of APAC coming from international biopharma brands • Craft booth activities and leverage on our marketing activities to increase your market presence • eClinical trials and big data management solutions providers • Manufacturing solution providers (upstream, downstream) • Facility HVAC, cleanroom and containment equipment providers • Country governments / trade agencies • Legal and compliance firms • Consultants and banks Over 70% already sold To book a booth, contact: Kenneth Lai at +65 6322 2792, kenneth.lai@terrapinn.com • 3rd party logistics providers • Cold chain packaging companies • Distributors in Asia Pacific • Executive search firms • Laboratory equipment providers The BioPharma Asia Opportunity The BioPharma Asia Facts You’ve got goals? We can help you achieve them. We can work with you to achieve your targets in 2015 by positioning your brand in front of the Asia Pacific biopharmaceutical industry. Who attends? + Engage with potential clients Generate leads, leads and more leads! • Exhibit at the show • Market your whitepaper with Total BioPharma • Work out a visitor campaign with us • Leverage on lead generation activities • Host a dedicated closed door workshop to reach your target audience • Network with potential clients without fighting your competitors at a private luncheons Pharma • Lead a roundtable discussion, hear industry issues and present your solutions • Utilise the networking app and our networking activities Biotech RI Brand your company and products Be a thought leader and educator • Leverage on our social media channels to expand your networks Join a panel or moderate during discussion platforms • Write an e-book that promotes your industry knowledge Take up premium slots in the Total BioPharma newsletter and gain maximum outreach through our database • Get involved in our “new product, latest launch” ideas Lead an interactive clinic within the conference agenda • Brand activities within the event that are aligned with your company’s direction • Share a case study and discuss trends as a speaker • • • Benefits Diamond Platinum Gold Plenary forum moderator 1 day Plenary presentation slot 1 x 20 mins Networking socials sponsor 1 Private hospitality benefits (private luncheon & cocktail sponsorship) Yes Yes Lead generation via content E-book 1 1 Presentation slots 1 1 1 Lead generation via social media campaign 4 3 2 Silver Bronze Exhibitor CRO CMO Government Consultant Hospital Investor Where from? Europe Asia 17% 1 of the Wo st rld Re 68% 5% Host roundtable session 4 4 2 1 Onfloor value chain speaking sessions 3 3 2 1 1 Onsite and event marketing logo branding Diamond Platinum Gold Silver Bronze Exhibitor Exhibition booth 36 sqm 24 sqm 18 sqm 12sqm 9sqm 9sqm VIP Passes for company representatives 10 7 5 3 2 1 Passes to exhibition 10 6 6 4 3 2 VIP Passes for clients 15 10 8 5 3 3 Access to networking app Unlimited Unlimited Unlimited Unlimited Unlimited Unlimited Price (SGD) 85,000 and above 80,000 60,000 35,000 25,000 15,000 Contact Kenneth Lai to discuss sponsorship & exhibition opportunities on +65 6322 2792 or Kenneth.lai@terrapinn.com Australia USA 3% 7% Contact Kenneth Lai on +65 6322 2792 or Kenneth.lai@terrapinn.com to find out how you can best profile your company at Asia’s leading regional biopharma event. 2000 + 800 + 600 + 30 + 5 + 2 + 3 Industry stakeholders 1-to-1 meetings C-level executives Hours of networking Conference brands Research symposiums On-floor seminar sessions Event partners GOLD SPONSOR PLATINUM SPONSOR SILVER SPONSORS BRONZE SPONSORS knows your target EXHIBITORS MEDIA PARTNERS & ASSOCIATIONS The BioPharma series For decades, Terrapinn has been hosting BioPharma Conventions across the globe. Leading international pharmaceutical and biotech companies as well as notable industry figures have participated as keynote speakers and delegates across the various conference agendas. These events have received the endorsement of long established societies and associations and the support of some of the industry’s biggest service providers. The BioPharma Conventions are highly prestigious amongst industry professionals. “NO LONGER CHEAP CHINA” Shaun Rein Managing Director, China Market Research Group and Author of The End of Copycat China Wednesday, 25 March, 2015; 09:00-09:45 am Shaun tells you why the changing demographics in China means new business opportunities and no more counterfeit goods. 19-21 October 2015, Seoul Renaissance Hotel, Seoul,South Korea 3-4 November 2015, Mexico City, Mexico 9-10 November 2015, 23-25 March 2015, The Lalit Mumbai, India Suntec Singapore Convention & Exhibition Centre, Singapore Special discounts are available when booking for multiple events at one time. Call +65 6322 2770 to find out more
